J 2019

Sensory profiles and immune-related expression patterns of patients with and without neuropathic pain after peripheral nerve lesion

HELD, Melissa; Franziska KARL; Eva VLČKOVÁ; Aneta RAJDOVÁ; Fabiola ESCOLANO-LOZANO et al.

Základní údaje

Originální název

Sensory profiles and immune-related expression patterns of patients with and without neuropathic pain after peripheral nerve lesion

Autoři

HELD, Melissa; Franziska KARL; Eva VLČKOVÁ; Aneta RAJDOVÁ; Fabiola ESCOLANO-LOZANO; Christian STETTER; Richa BHARTI; Konrad U. FÖRSTNER; Ladislav DUŠEK; Mathias LEINDERS; Frank BIRKLEIN; Josef BEDNAŘÍK; Claudia SOMMER a Nurcan ÜÇEYLER

Vydání

Pain, LIPPINCOTT WILLIAMS & WILKINS, 2019, 0304-3959

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30103 Neurosciences

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 5.483

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/19:00112744

Organizační jednotka

Lékařská fakulta

UT WoS

000512905700016

EID Scopus

2-s2.0-85072747523

Klíčová slova anglicky

Nerve lesion; Neuropathic pain; Sensory profile; Quantitative sensory testing; mRNA

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 2. 3. 2020 08:52, Mgr. Tereza Miškechová

Anotace

V originále

In this multicenter cross-sectional study, we determined sensory profiles of patients with (NL-1) and without neuropathic pain (NL-0) after nerve lesion and assessed immune-related systemic gene expression. Patients and matched healthy controls filled in questionnaires and underwent neurological examination, neurophysiological studies, quantitative sensory testing, and blood withdrawal. Neuropathic pain was present in 67/95 (71%) patients (NL-1). Tactile hyperalgesia was the most prominent clinical sign in NL-1 patients (P , 0.05). Questionnaires showed an association between neuropathic pain and the presence of depression, anxiety, and catastrophizing (P , 0.05 to P , 0.01). Neuropathic pain was frequently accompanied by other chronic pain (P , 0.05). Quantitative sensory testing showed ipsilateral signs of small and large fiber impairment compared to the respective contralateral side, with elevated thermal and mechanical detection thresholds (P , 0.001 to P , 0.05) and lowered pressure pain threshold (P , 0.05). Also, more loss of function was found in patients with NL-1 compared to NL-0. Pain intensity was associated with mechanical hyperalgesia (P , 0.05 to P , 0.01). However, quantitative sensory testing did not detect or predict neuropathic pain. Gene expression of peptidylglycine a-amidating monooxygenase was higher in NL patients compared with healthy controls (NL-1, P , 0.01; NL-0, P , 0.001). Also, gene expression of tumor necrosis factor-a was higher in NL-1 patients compared with NL-0 (P , 0.05), and interleukin-1ß was higher, but IL-10 was lower in NL-1 patients compared with healthy controls (P , 0.05 each). Our study reveals that nerve lesion presents with small and large nerve fiber dysfunction, which may contribute to the presence and intensity of neuropathic pain and which is associated with a systemic proinflammatory pattern.

Návaznosti

MUNI/A/1419/2018, interní kód MU
Název: Diagnostika a patofyziologie neuropatické bolesti (Akronym: PNB)
Investor: Masarykova univerzita, Diagnostika a patofyziologie neuropatické bolesti, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty
602133, interní kód MU
Název: ncRNAPain - Non-coding RNAs in neurogenic and neuropathic pain mechanisms and their application for risk assessment, patient stratification and personalised pain medicine (Akronym: ncRNAPain)
Investor: Evropská unie, ncRNAPain - Non-coding RNAs in neurogenic and neuropathic pain mechanisms and their application for risk assessment, patient stratification and personalised pain medicine, Spolupráce